Latest Breaking News On - Tourmaline bio inc - Page 6 : vimarsana.com

Tourmaline Bio, Inc s (NASDAQ:TRML) top owners are retail investors with 58% stake, while 11% is held by institutions

Key Insights Significant control over Tourmaline Bio by retail investors implies that the general public has more power.

Sandeep kulkarniCompany ownershipPfizer incTourmaline bio incHydra llcPublic company ownershipTourmaline bioDeep track capitalPrivate companiesRetail investorsHare registry

Tourmaline Bio Stock: Time For A Pause (NASDAQ:TRML)

Tourmaline Bio Stock: Time For A Pause (NASDAQ:TRML)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkParvinder thiaraDante alighieriNovo nordiskSandeep kulkarniCompany overviewTourmaline bio incInhibition company websitePipeline company websiteTourmaline bioNew york cityTalaris therapeuticsAnalyst commentary

Tourmaline Bio (NASDAQ:TRML) Sets New 52-Week High at $33 66

Tourmaline Bio (NASDAQ:TRML) Sets New 52-Week High at $33 66
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sandeep chidambar kulkarniAaron kantoffLeerink partnrsPiper sandlerTourmaline bio incSecurities exchange commissionJefferies financial groupTourmaline bioGet free reportFinancial groupBio trading downChidambar kulkarniExchange commissionDirector aaron kantoffTourmaline bio daily

Tourmaline Bio (NASDAQ:TRML) Sets New 1-Year High at $33 66

Tourmaline Bio (NASDAQ:TRML) Sets New 1-Year High at $33 66
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sandeep chidambar kulkarniCaley casteleinLeerink partnrsJefferies financial groupTourmaline bio incSecurities exchange commissionTourmaline bioGet free reportFinancial groupBio stock downChidambar kulkarniExchange commissionDirector caley casteleinTourmaline bio daily

Analysts Set Tourmaline Bio, Inc (NASDAQ:TRML) PT at $49 75

Analysts Set Tourmaline Bio, Inc (NASDAQ:TRML) PT at $49 75
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sandeep chidambar kulkarniLeerink partnrsCaley casteleinSecurities exchange commissionJefferies financial groupTourmaline bio incTourmaline bioGet free reportFinancial groupChidambar kulkarniExchange commissionDirector caley casteleinGet freeTourmaline bio daily